A combination of 3 g of ticarcilin and 200 mg of clavulanic acid was administered intravenously to six healthy male volunteers, after which the concentrations of these agents in serum and blister fluid were measured. The ratio of the two drugs in serum varied from 15:1 (ticarcillin-clavulanic acid) at the time of administration to 28:1 at 30 min and 62:1 at 5 h after injection. Both agents penetrated blister fluid rapidly, the ratio being 33:1 at 1 h and 66:1 at 3 h. The elimination rates of these agents were different, but for each compound they were similar in serum and blister fluid.
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Ticarcillin, a wide-spectrum penicillin (7) , is susceptible to a number of ,B-lactamases, including the plasmid-mediated enzymes found in the Enterobacteriaceae (and other genera) such as the Richmond and Sykes group III (6) and the (-lactamases of Bacteroidesfragilis and Staphylococcus aureus. Clavulanic acid is a potent inhibitor of many such enzymes (5, 9) . In vitro studies (1, 4) The subjects were six male volunteers between the ages of 24 and 40 years. They were of normal body build and had a mean (t standard deviation) weight and height of 78.7 ± 8.1 kg and 1.78 ± 0.07 m, respectively. At the time of the study, no subject was receiving any form of medication. Written informed consent was obtained. One week before the trial, a full medical history, physical examination, and biochemical and hematological profiles were obtained; hepatic and renal function were assessed as normal, and no previous history of atopy, allergy to P-lactam compounds, or hepatic, renal, or gastrointestinal disease was found.
To induce blisters, two 1-cm2 0.2% cantharides plasters were taped to the flexor aspect of a forearm of each volunteer the evening before the study.
At the start of the study, an intravenous cannula was inserted into a vein in the other forearm and was kept patent with 1-ml doses of heparinized saline (100 U/ ml). The subjects emptied their bladders, and predose blood samples were taken for base-line assay. Ticarcillin (3 g) and clavulanic acid (0.2 g) (batch no. CtIlB01;
Beecham Research Laboratories) dissolved in 20 ml of sterile water were injected into the antecubital vein of the opposite arm over 3 min at time 0 h. After discarding the first 2 ml, blood samples were taken from the cannula at 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 7, and 8 h. Blister fluid was collected at 0.5, 1, 2, 3, 4, 5, 6, and 7 h and placed on six sterile 6-mm assay disks. The volume of fluid taken was measured by reweighing these disks and was found to be about 20 p1. Urine collections were taken at 0 to 2, 2 to 4, 4 to 8, 8 to 12, and 12 to 24 h. The volume and pH were noted, and a 20-ml sample was kept for assay.
Assays were performed within 2 h of sample collection. The assay for ticarcillin was carried out by a routine agar plate diffusion technique with Pseudomonas aeruginosa NCTC 10701 as the indicator organism and Penassay no. 1 (Oxoid, Basingstoke, U.K.) as the antibiotic medium. Serum standards were prepared in human serum, and urine standards were prepared in phosphate-buffered saline (pH 6.6) in which urine samples were diluted when necessary. Blister fluid sample standards were made up in 70o serum, thus simulating the protein content of actual blister fluid (10).
The assay for clavulanic acid was performed in a similar manner. The medium used was Penassay no. 2 (Oxoid) incorporating 35 ,ug of benzylpenicillin per ml, and the indicator organism was Klebsiella pneumoniae. The plates were used within 3 h of pouring. Standards in this method were made up in 100% horse serum and 70%o horse serum for serum and blister fluid, respectively, it having previously been shown that horse serum and human serum gave equivalent results (preliminary results, data not shown). The 95% ANTIMICROB. AGENTS CHEMOTHER.
confidence limits of the serum assays were 16.4 and 16.8%, respectively, for ticarcillin and clavulanic acid.
The pharmacokinetic analysis of individual data was performed by standard graphical methods.
RESULTS
The levels of ticarcillin and clavulanic acid in serum and blister fluid at various times are shown in Table 1 . The pharmacokinetic data are shown in Table 2 lanic acid -but is possibly related to the greater volume of distribution of clavulanic acid. There was also a greater nonrenal elimination of clavulanic acid as compared with ticarcillin, a result presumably related to the metabolism of clavulanic acid (2) .
When formulating a mixture of P-lactamase inhibitors and p-lactams, it is important to know how much inhibitor to have present to protect the P-lactam. In vitro studies of ticarcillin-resistant Enterobacteriaceae (4) suggest that between 5 and 10 ,ug of clavulanic acid per ml are required before clinically relevant synergy (i.e., a reduction in the minimal inhibitory concentration of ticarcillin to s16 txg/ml) is obtained. If this were the case, then this formulation of ticarcillin and clavulanic acid would not be expected to be active clinically, as levels of greater than 5 ,ug/ml are obtained in the serum only in the first hour and do not reach 5 ,ug/ml at all in blister fluid. However, a dynamic in vitro model which simulated the expected in vivo levels (R. J. Boon, P. Masters, and R. Sutherland (8, 9) .
This combination of ,B-lactams plus inhibitor should prove to be efficacious against a wide range of bacterial pathogens, including P. aeruginosa, the Enterobacteriaceae, S. aureus, and gram-negative anaerobic bacilli. The results of clinical trials are awaited with interest.
